13F-HR filed by Fairmount Funds Management LLC
Fairmount Funds Management LLC filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-12, with 15 holding rows worth $164,989,000.
- Accession
- 0001802528-20-000004
- Filer
- CIK 1802528
- Filed
- 2020-02-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 15 entries on the cover page, a total value of $164,989,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $164,989,000 with VALUE read as thousands by filing date, 13F file number 028-19908. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZOGENIX INC. | 98978L204 | Common Stock | 466,875 | $24,338,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 988,999 | $23,617,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 515,788 | $22,065,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 841,714 | $18,046,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 453,890 | $12,564,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 78,138 | $12,543,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 128,662 | $12,269,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 161,949 | $10,005,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 810,073 | $9,980,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 401,609 | $7,699,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 29,676 | $4,129,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 624,956 | $3,768,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 80,238 | $1,998,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 165,318 | $1,828,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 341,743 | $140,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802528-20-000004 | this filing | 2020-02-12 | acceptance time not in the bulk data set |